echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Chinese experts take the lead in proposing a predictive model of recurrence of thymus tumors to solve the world's medical problems

    Chinese experts take the lead in proposing a predictive model of recurrence of thymus tumors to solve the world's medical problems

    • Last Update: 2020-07-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Do patients with thymus tumors need to undergo complementary therapy after surgery? What should be the frequency of scientific follow-up? Reporters learned on the 17th, China's 15 provinces and autonomous regions 18 hospitals of medical experts to work together to study, the first to put forward the recurrence of thymus tumor prediction model (hereinafter referred to as the prediction model) and its prognosis long-termmanagementsignificance, to solve the global chest surgeons problemsthymus is located in the human compartment, thymus tumor is the most common type of isolation tumorDue to the large base of Chinese mouth, the actual incidence of thymus tumor sillised is not lowit is understood that the prediction model put forward by the Chinese thymus tumor collaboration group (ChART) research team, led by Professor Fang Wentao, director of thoracic surgery at Shanghai Chest Hospital, shows that 80% of patients are in the low-risk population of recurrence, and that these patients do not need to undergo complementary treatment after surgery; It is understood that the prediction model proposes targeted treatment strategies according to different types of recurrence transferpredictive model sputions are proposed for postoperative follow-up in patients with thymus tumorsPatients in the high-risk group should undergo a comprehensive examination for 6 years, recommended to review every six months for the first 3 years and once every year after 3 years, and the scope of the examination should cover the chest, abdominal cavity, skull, bones and other parts of the whole bodyFor patients with low risk, the average recurrence time is 10 years, and is limited to the area of the area or chest cavity, so only one regular chest CT follow-up is required once a yearthe latest study, published in the International Association for the Study of Lung Cancer (ISLAC), an international authoritative academic journal in the field of chest cancer, provides strong clinical guidance and recommendations for the management model of thymus tumor patients in China and around the worldChinese experts have pioneered the prediction model of recurrence of thymus tumors and their significance to the long-term management of prognosis, which solves the difficult problems that plague thoracic surgeons around the worldProfessor Fang Wentao,of Shanghai Chest Hospital, said in an interview on the 17th that in the past, thymus tumor surgery often have to do radiotherapy, chemotherapy to prevent the risk of recurrence; However, if the examination is not careful enough, it will delay some patients with recurrent metastasisThese are the international problems that plague thoracic surgeons all year round, he admitsthe results of the study of Chinese experts, immediately received wide attention from the international communityTwo hospitals in Rome, Italy, and a national cancer center used a model of postoperative recurrence prediction of thymus tumors to manage patients after surgery The results show that the model proposed by Chinese experts is accurate and effective, and has universality and promotion, and can be applied to patients with thymus tumors worldwide Professor Fang Wentao's team is leading the main member units of the China Anti-Cancer Association's Cancer Society' Cancer Commission, and based on this predictive model results, a national multi-center prospective clinical study is being carried out with a view to further verifying the accuracy and effectiveness of postoperative assisted treatment of thymus tumors through evidence-based medical basis it is learned that in 2012, Shanghai Chest Hospital led the formation of the "China Thymus Tumor Collaboration Group"; Over the years, Shanghai Chest Hospital, in collaboration with various units to carry out various aspects of disease management research, for the international thymus tumor diagnosis and treatment standards to contribute to China's strength (Complete) Source: China News Network
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.